Purdue Fends Off Generic OxyContin Competition
Purdue Pharma LP has settled separately two patent infringement suits over generic versions of its painkiller OxyContin, stipulating that the generic makers must stop producing their generics if the settlements receive...To view the full article, register now.
Already a subscriber? Click here to view full article